Insulin sensitizers for the treatment of non-alcoholic fatty liver disease

Insulin sensitizers for the treatment of non-alcoholic fatty liver disease

Item
http://www.wikidata.org/entity/Q38209666
Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureAre women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysisNon-alcoholic fatty liver disease: The diagnosis and management.Effect of Vitamin E and Metformin on Fatty Liver Disease in Obese Children- Randomized Clinical TrialExtracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivityCrude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model.Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population.Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients.Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease.Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present.The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue.Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients.Microbiota, NASH, HCC and the potential role of probiotics.The Beneficial Effect of Anthocyanidin-Rich Vitis vinifera L. Grape Skin Extract on Metabolic Changes Induced by High-Fat Diet in Mice Involves Antiinflammatory and Antioxidant Actions.Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease.
P2860

Insulin sensitizers for the treatment of non-alcoholic fatty liver disease

Item
http://www.wikidata.org/entity/Q38209666
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
@en
type
label
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
@en
prefLabel
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932